PCSK9 and early-onset autosomal dominant Alzheimer disease: Given the role of PCSK9 in apoptosis, lipoprotein receptor metabolism, and inflammation, PCSK9 might play a regulatory role in Alzheimer’s disease (AD) pathogenesis (Figure 2).